PDB14 ECONOMIC EVALUATION OF DETEMIR-BASED BASAL/BOLUS THERAPY VERSUS NEUTRAL PROTAMINE HAGEDORN-BASED BASAL/BOLUS THERAPY FOR TYPE-1 DIABETES IN A DUTCH SETTING
May 1, 2005, 00:00 AM
10.1016/S1098-3015(10)62947-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)62947-6/fulltext
Section Title :
Section Order :
384
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62947-6&doi=10.1016/S1098-3015(10)62947-6